Trade

Hindustan Bio Sciences share price

Extreme risk
  • 69%Low risk
  • 69%Moderate risk
  • 69%Balanced risk
  • 69%High risk
  • 69%Extreme risk
  • 8.80(-3.51%)
    April 16, 2026 15:55:24 PM IST
    • NSE
    • BSE
  • Vol : 3.41 K (NSE + BSE)
    Last 20 day avg : 4.75 K

Hindustan Bio Sciences is trading -3.51% lower at Rs 8.80 as compared to its last closing price. Hindustan Bio Sciences has been trading in the price range of 9.57 & 8.67. Hindustan Bio Sciences has given 73.06% in this year & 12.87% in the last 5 days. Hindustan Bio Sciences has TTM P/E ratio 40.06 as compared to the sector P/E of 42.24.The company posted a net profit of 0.08 Crores in its last quarter.Listed peers of Hindustan Bio Sciences include Sun Pharmaceutical Industries (-0.21%), Divi's Laboratories (1.95%), Torrent Pharmaceuticals (0.06%).The Mutual Fund holding in Hindustan Bio Sciences was at -% in . The MF holding has - from the last quarter. The FII holding in Hindustan Bio Sciences was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 17, 2026, 12:15 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -0.84
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    2.77
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
8.67
Highest
9.57
52 week range
Lowest
5.00
Highest
10.32
Hindustan Bio Sciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bearish
1,693.15-0.214,06,233.8337.465.960.920.50
Divi's Laboratories
Moderately Bullish
6,297.001.951,67,220.6472.7710.670.500.01
Torrent Pharmaceuticals
Bullish
4,158.350.061,41,172.6575.4519.160.8117.62
Dr Reddy's Laboratories
Bearish
1,221.250.241,01,944.2219.143.230.622.34
Lupin
Bullish
2,322.70-0.711,06,362.7232.066.230.5111.80
Hindustan Bio Sciences Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-01-31Quarterly Results
2025-10-31Quarterly Results
2025-07-31Quarterly Results
2025-05-30Audited Results
2025-04-23Others
About the company Hindustan Bio Sciences
  • IndustryBiotechnology & Drugs
  • ISININE597C01021
  • BSE Code532041
  • NSE Code
Hindustan Bio Sciences Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical products. The Company is involved in the trading of drugs and medicine. The Company has manufacturing facilities for dry and liquid injectables, liquid/dry syrups, eye/ear/nasal drops, pre-filled syringes and non-sterile/sterile ointments, tablets, and capsules. Its products include tablets, capsules, drops, externels, and syrups.
  • Management Info
  • Venkata Rama Raju JampanaExecutive Chairman of the Board, Managing Director
  • Jaison GeorgeChief Financial Officer, Director
  • Shailendra VyasCompliance Officer, Company Secretary
Hindustan Bio Sciences Share Price FAQs

Hindustan Bio Sciences is trading at 8.80 as on Thu Apr 16 2026 10:25:24. This is -3.51% lower as compared to its previous closing price of 9.12.

The market capitalization of Hindustan Bio Sciences is 9.01 Cr as on Thu Apr 16 2026 10:25:24.

The 52 wk high for Hindustan Bio Sciences is 10.32 whereas the 52 wk low is 5.00

Hindustan Bio Sciences can be analyzed on the following key metrics -

  • TTM P/E: 40.06
  • Sector P/E: 42.24
  • Dividend Yield: 0.00%
  • D/E ratio: -

Hindustan Bio Sciences reported a net profit of 0.10 Cr in 2025.